Finance

Beta
Lists
GRI:NASDAQ
GRI Bio Inc
$2.25
-2.60%
(-0.060) 1D
Jun 11, 1:53:32 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRI...
Open
$2.27
High
$2.35
Low
$2.20
Mkt. cap
3.98M
Avg. vol.
44.69K
Volume
45.20K
52-wk high
$80.36
52-wk low
$1.97
EPS
-$87.47
Beta
-1.17
Shares outstanding
1.77M
No. of employees
4
Open
$2.27
High
$2.35
Low
$2.20
Mkt. cap
3.98M
Avg. vol.
44.69K
Volume
45.20K
52-wk high
$80.36
52-wk low
$1.97
EPS
-$87.47
Beta
-1.17
Shares outstanding
1.77M
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to GRI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GRI in the last 3 months.
Highest
Current $2.25
$32.00 (+1,322.22%)
Average
$21.00 (+833.33%)
Lowest
$10.00 (+344.44%)
News stories
From sources across the web
About GRI Bio Inc
CEO-
Employees4
Founded2009
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Websitegribio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.88M
1.77M
1.63M
361.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.60M
1.03M
1.64M
Operating expense
2.90M
3.36M
2.66M
2.00M
Total operating expenses
2.90M
3.36M
2.66M
2.00M
Operating income
-2.90M
-3.36M
-2.66M
-2.00M
Other non operating income
-
-
-
-
EBT including unusual items
-2.89M
-3.36M
-2.66M
-2.00M
EBT excluding unusual items
-2.89M
-3.36M
-2.66M
-2.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.89M
-3.36M
-2.66M
-2.00M
Net profit margin
-
-
-
-
Earnings per share
-36.68
-35.84
-116.61
-1.61
Interest and investment income
5.00K
6.00K
5.00K
5.00K
Interest expense
-
-
-
-
Net interest expenses
5.00K
6.00K
5.00K
5.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.90M
-3.36M
-2.66M
-2.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer